SV2006002156A - Compuesto farmaceutico ref. 00346/sv - Google Patents

Compuesto farmaceutico ref. 00346/sv

Info

Publication number
SV2006002156A
SV2006002156A SV2005002156A SV2005002156A SV2006002156A SV 2006002156 A SV2006002156 A SV 2006002156A SV 2005002156 A SV2005002156 A SV 2005002156A SV 2005002156 A SV2005002156 A SV 2005002156A SV 2006002156 A SV2006002156 A SV 2006002156A
Authority
SV
El Salvador
Prior art keywords
pharmaceutical compound
compound ref
ref
methylpiridin
serinprotease
Prior art date
Application number
SV2005002156A
Other languages
English (en)
Inventor
Julie Kay Bush
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SV2006002156A publication Critical patent/SV2006002156A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EL D-TARTRATO DE 1-(INDOL-6-CARBONIL-D-FENILGLICINIL)-4-(1-METILPIRIDIN-4-IL) PIPERAZINA FORMA UNA SAL CRISTALINA ESTABLE Y ES UN INHIBIDOR DE LA SERINPROTEASA FACTOR XA, UTIL EN EL TRATAMIENTO DE TRASTORNOS CARDIOVASCULARES
SV2005002156A 2004-06-30 2005-06-29 Compuesto farmaceutico ref. 00346/sv SV2006002156A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58359904P 2004-06-30 2004-06-30

Publications (1)

Publication Number Publication Date
SV2006002156A true SV2006002156A (es) 2006-02-15

Family

ID=35276192

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002156A SV2006002156A (es) 2004-06-30 2005-06-29 Compuesto farmaceutico ref. 00346/sv

Country Status (19)

Country Link
US (1) US20070249623A1 (es)
EP (1) EP1763521A1 (es)
JP (1) JP2008505075A (es)
CN (1) CN1984903A (es)
AR (1) AR049659A1 (es)
AU (1) AU2005267579A1 (es)
BR (1) BRPI0512245A (es)
CA (1) CA2570634A1 (es)
EA (1) EA010307B1 (es)
EC (1) ECSP067105A (es)
IL (1) IL179903A0 (es)
MA (1) MA28842B1 (es)
MX (1) MXPA06015112A (es)
NO (1) NO20070486L (es)
PE (1) PE20060480A1 (es)
SV (1) SV2006002156A (es)
TW (1) TW200603806A (es)
WO (1) WO2006011955A1 (es)
ZA (1) ZA200610091B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
CN107365304A (zh) * 2017-08-01 2017-11-21 齐宜涛 一种治疗心血管疾病的化合物及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
JP2002539194A (ja) * 1999-03-15 2002-11-19 ノボ ノルディスク アクティーゼルスカブ 新規の（２ｒ，３ｒ，４ｒ）−３，４−ジヒドロキシ−２−ヒドロキシメチルピロリジンの塩
AU5414000A (en) * 1999-06-14 2001-01-02 Eli Lilly And Company Compounds
US6448293B1 (en) * 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0019228D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
BR0209605A (pt) * 2001-05-14 2004-03-23 Pfizer Prod Inc Sais tartarato de 5,8,14-triazatetraciclo[10.3.1.0.²,¹¹.04,9]-hexadeca-2(11), 3,5,7,9-pentaeno
TWI257389B (en) * 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound

Also Published As

Publication number Publication date
US20070249623A1 (en) 2007-10-25
IL179903A0 (en) 2007-05-15
JP2008505075A (ja) 2008-02-21
EA010307B1 (ru) 2008-08-29
ZA200610091B (en) 2008-02-27
MXPA06015112A (es) 2007-02-08
AU2005267579A1 (en) 2006-02-02
CN1984903A (zh) 2007-06-20
EA200700186A1 (ru) 2007-06-29
AR049659A1 (es) 2006-08-23
PE20060480A1 (es) 2006-07-13
CA2570634A1 (en) 2006-02-02
NO20070486L (no) 2007-01-25
EP1763521A1 (en) 2007-03-21
WO2006011955A1 (en) 2006-02-02
BRPI0512245A (pt) 2008-02-19
ECSP067105A (es) 2007-01-26
TW200603806A (en) 2006-02-01
MA28842B1 (fr) 2007-09-03

Similar Documents

Publication Publication Date Title
RS51106B (sr) Derivati prolina i njihova upotreba kao inhibitora dipeptidil peptidaze iv
RS52653B (en) INDOLINON DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROSE DISEASES
RS52283B (sr) 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilkarbonil)-n- metil-amino)-anilino)-1-fenil-metilen]-6-metoksikarbonil-2- indolinon-monoetansulfonat i njegova primena u farmaceutskoj kompoziciji
CL2004000409A1 (es) Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
CY1109529T1 (el) 2-(αμινο-υποκατεστημενες)-4-αρυλο πυραμιδινες και σχετικες ενωσεις που χρησιμευουν στην αγωγη φλεγμονωδων νοσηματων
RS52110B (en) DIPEPTIDIL PEPTIDASE INHIBITORS FOR TREATMENT OF DIABETES
ITVI20050152A1 (it) Cartuccia per la conservazione e l'erogazione sterile di un composto bifasico, particolarmente per una resina acrilica
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
CO5640087A2 (es) Composiciones de farmacos anti-inflamatorios no esteroideos descongestionantes y anti-histaminicos
CY1112173T1 (el) Η χρηση της cilobradine ή των φαρμακευτικα αποδεκτων αλατων αυτης για την θεραπεια ή την προληψη της καρδιακης ανεπαρκειας
SE0302488D0 (sv) New combination
RS54293B1 (en) PHARMACEUTICAL COMBINATION
AR048589A1 (es) Derivados de pirrolidina -3,4-dicarboxamida
SV2006002156A (es) Compuesto farmaceutico ref. 00346/sv
HK1070363A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
AP2006003858A0 (en) New association of a sinus node if inhibitor and acalcium inhibitor, and pharmaceutical composition s containing it
SV2003001085A (es) Compuesto farmaceutico
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
GB0201882D0 (en) Organic compounds
HK1087638A1 (en) Use of tyrosine kinase inhibitors to treat diabetes
DOP2005000121A (es) Compuesto farmaceutico
ATE552888T1 (de) Elastasehemmer bei leukämie
ATE358487T1 (de) Kombination enthaltend cyamemazine und ein atypisches neuroleptikum
TNSN05304A1 (en) Use of tyrosine kinase inhibitor to treat diabetes
DE602004010186D1 (de) Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2

Legal Events

Date Code Title Description
FD Lapse